Clinical Utility Evidence for TissueCypher®
Gastro-Intestinal Disorder, Barrett Esophagus
About this trial
This is an interventional diagnostic trial for Gastro-Intestinal Disorder
Eligibility Criteria
Inclusion Criteria:
- Board-certified gastroenterologist or GI surgeon for at least two years
- Averages at least 20 hours per week of clinical and patient care duties over the last six months
- performs either diagnostic endoscopy, interventional endoscopy, upper GI surgery, or bariatric surgery
- practicing in the US
- english speaking
- access to the internet
- informed and voluntarily consented to be in the study
Exclusion Criteria:
- non-English speaking
- unable to access the internet
- not practicing in the US
- not averaging at least 20 hours per week of clinical or patient care duties over the last six months
- does not perform either diagnostic endoscopy, interventional endoscopy, upper GI surgery, or bariatric surgery
- does not voluntarily consent to be in the study
Sites / Locations
- QURE Healthcare
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Experimental
Experimental
Control Group
Intervention Group 1
Intervention Group 2
The control group does not receive educational materials about the TissueCypher diagnostic test and will treat their simulated patients with the current standard of care tools.
Intervention group 1 receives educational materials about the TissueCypher diagnostic test. These materials detail what the test does, how it is used, the validity and specifications of the test, and how to read its test report. This intervention group is then forced to use the test results in treating their simulated patients.
Intervention group 2 receives educational materials about the TissueCypher diagnostic test. These materials detail what the test does, how it is used, the validity and specifications of the test, and how to read its test report. This intervention group then gets to decide whether or not they want to use the TissueCypher test results for their simulated patients.